Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXCELSIOR-CKD
NCT06322056Recruiting
- Sponsor
- Yonsei University
- Start
- May 2024
- Primary completion
- May 2029
- Countries
- 1
01
Overview
Randomised trial in chronic kidney disease (CKD), hypertension (HTN) and dyslipidemia (4 arms), sponsored by Yonsei University. Primary endpoint: Renal composite outcome up to 3 years. Started May 2024; status: recruiting.
02
Conditions
chronic kidney disease (CKD)hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT06322056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06322056.